Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes.
Hezemans FH, Wolpe N, O'Callaghan C, Ye R, Rua C, Jones PS, Murley AG, Holland N, Regenthal R, Tsvetanov KA, Barker RA, Williams-Gray CH, Robbins TW, Passamonti L, Rowe JB.
Hezemans FH, et al. Among authors: rua c.
PLoS Comput Biol. 2022 May 9;18(5):e1010079. doi: 10.1371/journal.pcbi.1010079. eCollection 2022 May.
PLoS Comput Biol. 2022.
PMID: 35533200
Free PMC article.
Clinical Trial.